Preclazide MV 0.2mg/500mg/80mg Tablet SR
Marketer
Precia Pharma
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Preclazide MV 0.2mg/500mg/80mg Tablet SR
Diaprex-M 0.2mg/500mg/80mg Extended-Release Tablets are classified as antidiabetic medications. This triple-combination therapy treats type 2 diabetes in adults by regulating blood glucose. Diaprex-M should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse reaction, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, vomiting, diarrhea, abdominal discomfort, headache, edema, blurred vision, and bone fractures. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before initiating therapy. Regular blood glucose monitoring is necessary, along with potential blood tests to evaluate blood cell counts and liver function.
Primary Ingredients of Preclazide MV 0.2mg/500mg/80mg Tablet SR
No text was provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Preclazide MV 0.2mg/500mg/80mg Tablet SR
Managing type 2 diabetes
Major Benefits of Preclazide MV 0.2mg/500mg/80mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Preclazide MV 0.2mg/500mg/80mg sustained-release tablet should be taken with food.
Common Side effects of Preclazide MV 0.2mg/500mg/80mg Tablet SR:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Preclazide MV 0.2mg/500mg/80mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Preclazide MV 0.2mg/500mg/80mg Sustained-Release tablets with food.
How Preclazide MV 0.2mg/500mg/80mg Tablet SR works:
Preclazide MV SR tablets (0.2mg/500mg/80mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Preclazide MV 0.2mg/500mg/80mg SR tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Preclazide MV 0.2mg/500mg/80mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCAUTION
The extended-release Preclazide MV 0.2mg/500mg/80mg tablet requires careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the patient's system.
DrivingCAUTION
Impaired driving may result from abnormally low or high blood glucose levels. Refrain from driving if such symptoms appear.
KidneyCAUTION
Exercise caution when administering Preclazide MV 0.2mg/500mg/80mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Preclazide MV 0.2mg/500mg/80mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment course.
LiverCAUTION
Patients with liver impairment should use Preclazide MV 0.2mg/500mg/80mg Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. In those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Preclazide MV 0.2mg/500mg/80mg Tablet SR :
NA
Facts to Know About Preclazide MV 0.2mg/500mg/80mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently